TITLE

Relapse after treatment with peginterferon a-2b alone or in combination with lamivudine in HBeA9 positive chronic hepatitis B

AUTHOR(S)
Flink, H. J.; Bustler, E. H. C.; Merican, I.; Nevens, F.; Kitis, G.; Cianciara, J.; de Vries, R. A.; Hansen, B. E.; Schalm, S. W.; Janssen, H. L. A.
PUB. DATE
October 2007
SOURCE
Gut;Oct2007, Vol. 56 Issue 10, p1485
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article about chronic hepatitis B, which appeared in the previous issue.
ACCESSION #
27148502

 

Related Articles

  • Lamivudine for the Treatment of Chronic Hepatitis B. Verhelst, David; Goffin, Eric // New England Journal of Medicine;02/24/2000, Vol. 342 Issue 8, p592 

    A letter to the editor is presented in response to an article focusing on the treatment of chronic Hepatitis B, by J.L. Dienstag and others in the October 21, 1999 issue.

  • Lamivudine for the Treatment of Chronic Hepatitis B. Dienstag, Jules L.; Brown, Nathaniel A.; Woessner, Mary // New England Journal of Medicine;02/24/2000, Vol. 342 Issue 8, p592 

    A response by Jules L. Dienstag, Nathaniel A. Brown and Mary Woessner to a letter to the editor about their article focusing on the treatment of chronic Hepatitis in the October 21, 1999 issue is presented.

  • IN RESPONSE. Henry L. Y. Chan; Joseph J. Y. Sung // Annals of Internal Medicine;9/6/2005, Vol. 143 Issue 5, p391 

    Presents a response from authors to a letter to the editor on their article about pegylated interferon in patients with hepatitis B, published previously in the journal "Annals of Internal Medicine."

  • Cost-Effectiveness in Hepatitis B. Weitzman, Gil; Jacobson, Ira // Annals of Internal Medicine;11/15/2005, Vol. 143 Issue 10, p757 

    Presents a letter to the editor about cost-effectiveness in Hepatitis B.

  • IN RESPONSE. Spiegel, Brennan M. R.; Martin, Paul; Kanwal, Fasiha // Annals of Internal Medicine;11/15/2005, Vol. 143 Issue 10, p758 

    Presents a response by the author to a letter to the editor about his article on the management of chronic hepatitis B infection.

  • Knowledge of the Pre-Core Mutation Variant of the Hepatitis B Virus. Lyra, Luiz; Parana, Raymundo; Cotrim, Helma // American Journal of Gastroenterology;Dec1991, Vol. 86 Issue 12, p1851 

    Presents a letter to the editor about the pre-core mutation variant of the hepatitis B virus.

  • Acute Hepatitis B in a Patient with Antibodies to Hepatitis B Surface Antigen Who Was Receiving Rituximab. Dervite, Isabelle; Hober, Didier; Morel, Pierre // New England Journal of Medicine;01/04/2001, Vol. 344 Issue 1, p68 

    A letter to the editor on acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was having rituximab therapy is presented.

  • Peginterferon and Lamivudine for Hepatitis B. Assy, N. Nimer; Hussein, Osamah // New England Journal of Medicine;12/30/2004, Vol. 351 Issue 27, p2879 

    A letter to the editor is presented in response to the article "Peginterferon and Lamivudine for Hepatitis B," by Partick Marcellin in the September 16, 2004 issue.

  • Peginterferon and Lamivudine for Hepatitis B. Marcellin, Patrick // New England Journal of Medicine;12/30/2004, Vol. 351 Issue 27, p2879 

    A response by Patrick Marcellin to a letter to the editor about his article "Peginterferon and Lamivudine for Hepatitis B" in the September 16, 2007 issue is presented.

  • Long-term lamivudine therapy in hepatitis B-associated membranous nephropathy? Y.-Y. Ng; W.-C. Yang; S.-T. Lee // Kidney International;Feb2006, Vol. 69 Issue 4, p776 

    A letter to the editor is presented in response to the article "Long-Term Lamivudine Therapy in Hepatitis B-Associated Membranous Nephropathy?" in the January 18, 2006 issue.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics